血管生成素1(ANGPT1)检测试剂盒(酶联免疫吸附试验法)

ELISA Kit for Angiopoietin 1 (ANGPT1)

ANG1; AGP1; AGPT; ANG-I

  • 血管生成素1(ANGPT1)检测试剂盒(酶联免疫吸附试验法)产品包装(模拟)
  • 血管生成素1(ANGPT1)检测试剂盒(酶联免疫吸附试验法)产品包装(模拟)
  • 血管生成素1(ANGPT1)检测试剂盒(酶联免疫吸附试验法)实验结果图
  • SEA008Hu.jpg标准曲线图
  • Certificate通过ISO 9001、ISO 13485质量体系认证

特异性

本试剂盒用于检测血管生成素1(ANGPT1),经检测与其它相似物质无明显交叉反应。
由于受到技术及样本来源的限制,不可能完成对所有相关或相似物质交叉反应检测,因此本试剂盒有可能与未经检测的其它物质有交叉反应。

回收率

分别于定值血清及血浆样本中加入一定量的血管生成素1(ANGPT1)(加标样品),重复测定并计算其均值,回收率为测定值与理论值的比率。

样本回收率范围(%)平均回收率(%)
serum(n=5)83-9590
EDTA plasma(n=5)86-9490
heparin plasma(n=5)81-9488

精密度

精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100
批内差:取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次,分别计算不同浓度样本的平均值及SD值。
批间差:选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定,每个样本使用同一试剂盒重复测定8次,分别计算不同浓度样本的平均值及SD值。
批内差: CV<10%
批间差: CV<12%

线性

在定值血清及血浆样本内加入适量的血管生成素1(ANGPT1),并倍比稀释成1:2,1:4,1:8,1:16的待测样本,线性范围即为稀释后样本中血管生成素1(ANGPT1)含量的测定值与理论值的比率。

样本1:21:41:81:16
serum(n=5)79-92%82-102%78-103%83-97%
EDTA plasma(n=5)87-99%90-101%80-93%88-103%
heparin plasma(n=5)85-97%85-99%83-91%82-96%

稳定性

经测定,试剂盒在有效期内按推荐温度保存,其活性降低率小于5%。
为减小外部因素对试剂盒破坏前后检测值的影响,实验室的环境条件需尽量保持一致,尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。

实验流程

1. 实验前标准品、试剂及样本的准备;
2. 加样(标准品及样本)100µL,37°C孵育1小时;
3. 吸弃,加检测溶液A100µL,37°C孵育1小时;
4. 洗板3次;
5. 加检测溶液B100µL,37°C孵育30分钟;
6. 洗板5次;
7. 加TMB底物90µL,37°C孵育10-20分钟;
8. 加终止液50µL,立即450nm读数。

实验原理

将血管生成素1(ANGPT1)抗体包被于96孔微孔板中,制成固相载体,向微孔中分别加入标准品或标本,其中的血管生成素1(ANGPT1)与连接于固相载体上的抗体结合,然后加入生物素化的血管生成素1(ANGPT1)抗体,将未结合的生物素化抗体洗净后,加入HRP标记的亲和素,再次彻底洗涤后加入TMB底物显色。TMB在过氧化物酶的催化下转化成蓝色,并在酸的作用下转化成最终的黄色。颜色的深浅和样品中的血管生成素1(ANGPT1)呈正相关。用酶标仪在450nm波长下测定吸光度(O.D.值),计算样品浓度。

相关产品

编号适用物种:Homo sapiens (Human,人)应用(仅供研究使用,不用于临床诊断!)
RPA008Hu01血管生成素1(ANGPT1)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPA008Hu02血管生成素1(ANGPT1)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPA008Hu03血管生成素1(ANGPT1)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAA008Hu01血管生成素1(ANGPT1)多克隆抗体WB,IHC,ICC/IF
PAA008Hu02血管生成素1(ANGPT1)多克隆抗体WB; IHC; ICC; IP.
FAA008Hu01抗血管生成素1(ANGPT1)多克隆抗体Flow cytometry.
LAA008Hu71血管生成素1(ANGPT1)多克隆抗体(生物素标记)WB
MAA008Hu23血管生成素1(ANGPT1)单克隆抗体WB; IHC; ICC; IP.
MAA008Hu24血管生成素1(ANGPT1)单克隆抗体ICC/IF
MAA008Hu21血管生成素1(ANGPT1)单克隆抗体WB
MAA008Hu25血管生成素1(ANGPT1)单克隆抗体ICC/IF
MAA008Hu22血管生成素1(ANGPT1)单克隆抗体WB
FAA008Hu04抗血管生成素1(ANGPT1)单克隆抗体Flow cytometry.
FAA008Hu02抗血管生成素1(ANGPT1)单克隆抗体Flow cytometry.
FAA008Hu08抗血管生成素1(ANGPT1)单克隆抗体Flow cytometry.
FAA008Hu06抗血管生成素1(ANGPT1)单克隆抗体Flow cytometry.
LAA008Hu72血管生成素1(ANGPT1)单克隆抗体(生物素标记)WB; IHC; ICC.
SEA008Hu血管生成素1(ANGPT1)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
MEA008Hu血管生成素1(ANGPT1)检测试剂盒(酶联免疫吸附试验法,小样本)Enzyme-linked immunosorbent assay for Antigen Detection.
SCA008Hu血管生成素1(ANGPT1)检测试剂盒(化学发光免疫分析法)Chemiluminescent immunoassay for Antigen Detection.
LMA008Hu血管生成素1(ANGPT1)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.

参考文献

杂志参考文献
TheriogenologyEvaluation of Changes in Doppler Ultrasonography Indices and Levels of Maternal Serum Angiogenic Factors throughout Pregnancy in Ewes[Science: Article]
J Atheroscler ThrombHigh Mobility Group Box 1 Promotes Angiogenesis from Bone Marrow-derived Endothelial Progenitor Cells after Myocardial Infarction[PubMed: 25735431]
Archives of Biological SciencesDiabetes-induced renal failure is associated with tissue inflammation and neutrophil gelatinase-associated lipocalin: Effects of resveratrol[publication:299492265_Diabetes-induced_renal_failu]
Am J Transl ResAngiopoietin-1 facilitates recovery of hematopoiesis in radiated mice[Pubmed:27347310]
Clinical researchIncreased plasma concentrations of interleukin 35 in patients with coronary artery disease[Journal:-19]
Turkish Journal of Medicl SciencesA new angiogenesis prognostic index with VEGFA, PlGF, and angiopoietin 1 predicts survival in patients with advanced gastric cancer[pubmed:28425270]
Sci Rep. Flunarizine suppresses endothelial Angiopoietin-2 in a calcium - dependent fashion in sepsis.[pubmed:28276491]
PeerJ The ratio of serum Angiopoietin-1 to Angiopoietin-2 in patients with cervical cancer is a valuable diagnostic and prognostic biomarker[pubmed:28584715]
Molecular&cellular proteomicsPrediction of Response to Sorafenib in Hepatocellular Carcinoma: A Marker Panel by Multiple Reaction Monitoring-Mass Spectrometry[pubmed:28550167]
Tumor BiologyCervical cancer cell–derived angiopoietins promote tumor progression[pubmed:28720059]
Free Patents onlineRHEUMATOID ARTHRITIS RELATED BIOMARKER[20170350884]
AnesthesiologyVasculotide, an angiopoietin-1 mimetic, restores microcirculatory perfusion and microvascular leakage and decreases fluid resuscitation requirements in …[Pubmed:28968277]
British Journal of AnaesthesiaVasculotide, an angiopoietin-1 mimetic, reduces pulmonary vascular leakage and preserves microcirculatory perfusion during cardiopulmonary bypass in rats[10.1016:j.bja.2018.05.049]
The Journal of Biological ChemistryToll-like receptor 2 deficiency hyperactivates the FoxO1 transcription factor and induces aging-associated cardiac dysfunction in mice[Pubmed:29929978]
Clinical Significance of Nectin-4 Expression in Metastasis and Angiogenesis for Tumor Relapse[Doi: 10.4143/crt.2018.214]
BIOLOGY OF REPRODUCTIONProstaglandin-mediated effects in early canine corpus luteum: In vivo effects on vascular and immune factors[Pubmed: 30929911]
Scientific ReportsAssociation between Upper-airway Surgery and Ameliorative Risk Markers of endothelial function in obstructive Sleep Apnea[Pubmed: 31882827]
Biochem Biophys Res CommunEffects of interleukin-6 and tumor necrosis factor-α on the expression of angiogenic and collagenolytic factors in premature and mature adipocytes[Pubmed: 32800538]
J Nutr BiochemEffects of protein malnutrition on haematopoietic regulatory activity of bone marrow mesenchymal stem cells[33705953]
Intensive Care Med ExpThe effect of targeting Tie2 on hemorrhagic shock-induced renal perfusion disturbances in rats[33997943]
Gynecol EndocrinolPotential of thrombospondin-1 in treatment of polycystic ovary syndrome rat model: a preliminary study[34282706]
Yonsei Med JRAR-Related Orphan Receptor: An Accelerated Preeclampsia Progression by Activating the JAK/STAT3 Pathway[Pubmed:35619579]